US 7,465,741 B2
C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
José Ignacio Andrés-Gil, Madrid (Spain); José Manuel Bartolomé-Nebreda, Toledo (Spain); Rosa Maria Alvarez-Escobar, Toledo (Spain); Margaretha Henrica Maria Bakker, Alsbach-Haehnlein (Germany); and Antonius Adrianus Hendrikus Petrus Megens, Beerse (Belgium)
Assigned to Janssen Pharmaceutica N.V., Beerse (Bulgaria)
Appl. No. 10/524,197
PCT Filed Aug. 12, 2003, PCT No. PCT/EP03/50374
§ 371(c)(1), (2), (4) Date Feb. 10, 2005,
PCT Pub. No. WO2004/016621, PCT Pub. Date Feb. 26, 2004.
Claims priority of application No. 02078322 (EP), filed on Aug. 12, 2002.
Prior Publication US 2005/0256119 A1, Nov. 17, 2005
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/44 (2006.01); C07D 401/00 (2006.01); C07D 491/00 (2006.01); C07D 498/00 (2006.01); C07D 515/00 (2006.01); C07D 513/00 (2006.01)
U.S. Cl. 514—291  [514/293; 544/360; 544/374; 546/83; 546/89] 8 Claims
 
1. A compound according to the general Formula (I)

OG Complex Work Unit Drawing
the pharmaceutically acceptable acid or base addition salts thereof, the stereochemically isomeric forms thereof or the N-oxide form thereof, wherein:
X is CH2, N—R7, S or O;
R7 is selected from the group of hydrogen, alkyl, Ar, Ar-alkyl, alkylcarbonyl, alkyloxycarbonyl and mono- and di(alkyl)aminocarbonyl;
R1 and R2 are each selected from the group of hydrogen, halo, hydroxy, —OSO2H, —OSO2CH3, alkyloxy, alkyloxyalkyloxy, alkyloxyalkyloxyalkyloxy, tetrahydrofuranyloxy, alkylcarbonyloxy, alkyloxyalkylcarbonyloxy, pyridinylcarbonyloxy, alkylcarbonyloxyalkyloxy, alkyloxycarbonyloxy, alkenyloxy, alkenyl-carbonyloxy, mono- or di(alkyl)aminoalkyloxy, —N—R10R11, alkylthio, Alk and Het,
with the proviso that at least one of R1 and R2 selected from the group consisting of
Alk and Het, wherein
Alk is cyano, CN—OH, CN-oxyalkyl, alkyl, alkyloxyalkyl, alkyloxyalkyloxyalkyl, alkyloxyalkyloxyalkyloxyalkyl, alkylcarbonylalkyl, alkylcarbonyloxyalkyl, alkyloxycarbonylalkyl, Ar-alkyl, Ar-carbonylalkyl, Ar-oxyalkyl, mono- or di(alkyl)aminoalkyl, mono- or di(alkylcarbonyl)aminoalkyl, mono- or di(alkyl)aminocarbonylalkyl, Het-alkyl, formyl, alkylcarbonyl, alkyloxycarbonyl, alkyloxyalkylcarbonyl, mono- or di(alkyl)aminocarbonyl, Ar-carbonyl and Ar-oxycarbonyl;
Ar is phenyl or naphthyl, optionally substituted with one or more halo, cyano, oxo, hydroxy, alkyl, formyl, alkyloxy or amino radicals;
Het is a heterocyclic radical selected from the group consisting of Het1, Het2 and Het3;
Het1 is an aliphatic monocyclic heterocyclic radical selected from the group consisting of pyrrolidinyl, dioxolyl, imidazolidinyl, pyrrazolidinyl, piperidinyl, dioxyl, morpholinyl, dithianyl, thiomorpholinyl, piperazinyl and tetrahydrofuryl;
Het2 is a semi-aromatic monocyclic heterocyclic radical selected from the group consisting of 2H-pyrrolyl, pyrrolinyl, imidazolinyl and pyrrazolinyl;
Het3 is an aromatic monocyclic heterocyclic radical selected from the group consisting of pyrrolyl, pyrazolyl, imidazolyl, furyl, thienyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, pyridinyl, pyrimidinyl, pyrazinyl, pyridazinyl and triazinyl; or an aromatic bicyclic heterocyclic radical selected from the group consisting of quinolinyl, quinoxalinyl, indolyl, benzimidazolyl, benzoxazolyl, benzisoxazolyl, benzothiazolyl, benzisothiazolyl, benzofuranyl and benzothienyl;
wherein each Het1, Het2 and Het3-radical may optionally be substituted on either a carbon or heteroatom with halo, hydroxy, alkyloxy, alkyl, Ar, Ar-alkyl, formyl, alkylcarbonyl or pyridinyl;
R10 and R11 are each, independently from each other, selected from the group consisting of hydrogen, alkyl, Ar, Ar-alkyl, pyrrolidinylalkyl, piperidinylalkyl, homopiperidinylalkyl, piperazinylalkyl, morpholinylalkyl, mono- or di(alkyl)aminoalkyl, alkylcarbonyl, alkenylcarbonyl, Ar-carbonyl, pyridinylcarbonyl, alkyloxycarbonyl, mono- or di(alkyl)aminocarbonyl, mono- or di(Ar)aminocarbonyl, mono- or di(alkyloxycarbonylalkyl)aminocarbonyl, pyrrolidinylcarbonyl, aminoiminomethyl, alkylaminoiminomethyl, N-benzylpiperazinyliminomethyl, alkylsulphonyl and Ar-sulphonyl ; or
R10 R11 may be taken together and with the N may form a monovalent radical selected from the group of

OG Complex Work Unit Drawing
wherein:
R12 is selected from the group consisting of hydrogen, alkyl, Ar, Ar-alkyl, Ar-alkenyl, alkylcarbonyl, alkyloxycarbonyl, alkyloxyalkylcarbonyl and mono-or di(alkyl)aminocarbonyl;
each ring being optionally substituted with q radicals R13, each radical independently from each other selected from the group of alkyl, oxo, Ar, Ar-alkyl, Ar-alkenyl and alkyloxycarbonyl and q being an integer ranging from 0 to 6 ;or
R1 and R2 may be taken together to form a bivalent radical —R1-R2 —selected from the group consisting of —CH2—CH2—CH2—CH2—, —CH═CH—CH2—CH2—, —CH2—CH2—CH═CH—, —CH2—CH═CH—CH2—and —CH═CH—CH═CH;
a and b area symmetric centers;
(CH2)m is a straight hydrocarbon chain of m carbon atoms, m being an integer ranging from 1 to 4;
Pir is a radical according to any one of Formula (IIa), (IIb) or (IIc)

OG Complex Work Unit Drawing
optionally substituted with n radicals R8, wherein:
each R8 is independently from each other, selected from the group of hydroxy, amino, nitro, cyano, halo and alkyl;
n is an integer ranging from 0 to 5;
R9 is selected from the group consisting of hydrogen, alkyl and formyl;
R3 represents an optionally substituted aromatic homocyclic or heterocyclic ring system together with an optionally substituted and partially or completely hydrogenated hydrocarbon chain of 1 to 6 atoms long with which said ring system is attached to the Pir radical and of which may contain one or more heteroatoms selected from the group of O , N and S;
alkyl represents a straight or branched saturated hydrocarbon radical having from 1 to 6 carbon atoms or a cyclic saturated hydrocarbon radical having from 3 to 6 carbon atoms, optionally substituted with one or more halo, cyano, oxo, hydroxy, formyl or amino radicals;
alkenyl represents a straight or branched unsatured hydrocarbon radical having one or more double bonds, optionally substituted with one or more halo, cyano, oxo, hydroxy, formyl or amino radicals ; and
halo is fluoro, chloro, bromo and iodo.